Dow Up 0.11% Nasdaq Up 0.50%

Alcobra Ltd. (ADHD)

-NasdaqGM
19.26 Up 0.07(0.36%) Aug 29, 4:00PM EDT
Prev Close:19.19
Open:19.13
Bid:N/A
Ask:25.30 x 1400
1y Target Est:33.63
Beta:1.935
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:18.78 - 19.50
52wk Range:12.29 - 26.96
Volume:163,840
Avg Vol (3m):133,715
Market Cap:263.13M
P/E (ttm):N/A
EPS (ttm):-1.54
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ADHD

Comparison

Symbol% ChgMkt Cap
ADHDUp 0.36%263.13M
JNJUp 0.76%292.55B
NVSUp 0.12%217.97B
SHPGDown 0.21%47.76B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.18
Quarterly EPS Est (Sep-14) :-0.56
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alcobra Ltd., a biopharmaceutical company, focuses on the development and commercialization of proprietary drug candidates. It offers most advanced product (MDX) for the treatment of attention deficit hyperactivity disorder (ADHD) and other cognit... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback